NCT00628121View on ClinicalTrials.gov

Clinical Pharmacological Study of GnRH Antagonist, Cetrorelix for Healthy Female Volunteer

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

February 28, 2007

Conditions
Premenopause
Interventions
DRUG

Cetrorelix

1, 2 or 3mg, subcutaneouly dosed with single dose

Trial Locations (1)

228-8520

Kitasato University East Hospital, Sagamihara

Sponsors

Collaborators (2)

Shionogi
AEterna Zentaris
All Listed Sponsors
collaborator

Shionogi

INDUSTRY

collaborator

AEterna Zentaris

INDUSTRY

lead

Nippon Kayaku Co., Ltd.

INDUSTRY